{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:21:08Z","timestamp":1790310068271,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["AI055946"],"award-info":[{"award-number":["AI055946"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.vaccine.2012.12.054","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T12:17:19Z","timestamp":1357301839000},"page":"1009-1011","source":"Crossref","is-referenced-by-count":12,"title":["Oral vaccination with an adenovirus-vectored vaccine protects against botulism"],"prefix":"10.1016","volume":"31","author":[{"given":"Shan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingtao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.12.054_bib0005","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4161\/hv.9420","article-title":"Botulinum neurotoxin vaccines: past history and recent developments","volume":"5","author":"Rusnak","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2012.12.054_bib0010","series-title":"Handbook for epidemiologists, clinicians and laboratory workers","article-title":"Botulism in the United States, 1899\u20131998","year":"1998"},{"issue":"October (42)","key":"10.1016\/j.vaccine.2012.12.054_bib0015","first-page":"1454","article-title":"Notice of CDC's discontinuation of investigational pentavalent (ABCDE) botulinum toxoid vaccine for workers at risk for occupational exposure to botulinum toxins","volume":"60","author":"CDC","year":"2011","journal-title":"Morb Mortal Wkly Rep (MMWR)"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.12.054_bib0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/gt.2008.181","article-title":"An adenoviral vector-based mucosal vaccine is effective in protection against botulism","volume":"16","author":"Xu","year":"2009","journal-title":"Gene Ther"},{"issue":"October (43)","key":"10.1016\/j.vaccine.2012.12.054_bib0025","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1016\/j.vaccine.2007.08.035","article-title":"Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine","volume":"25","author":"Zeng","year":"2007","journal-title":"Vaccine"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2012.12.054_bib0030","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0006-291X(90)90828-B","article-title":"The complete nucleotide sequence of the gene coding for botulinum type C1 toxin in the C-ST phage genome","volume":"171","author":"Kimura","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"issue":"August (17)","key":"10.1016\/j.vaccine.2012.12.054_bib0035","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody","volume":"99","author":"Nowakowski","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2012.12.054_bib0040","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","article-title":"Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate","volume":"66","author":"Byrne","year":"1998","journal-title":"Infect Immun"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.12.054_bib0045","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1128\/IAI.00166-11","article-title":"Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells","volume":"79","author":"White","year":"2011","journal-title":"Infect Immun"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.12.054_bib0050","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1128\/CVI.00496-09","article-title":"Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system","volume":"17","author":"Zichel","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"December (52)","key":"10.1016\/j.vaccine.2012.12.054_bib0055","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1016\/j.vaccine.2007.10.016","article-title":"Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A","volume":"25","author":"Yu","year":"2007","journal-title":"Vaccine"},{"issue":"May (21)","key":"10.1016\/j.vaccine.2012.12.054_bib0060","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.vaccine.2009.02.091","article-title":"The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate","volume":"27","author":"Yu","year":"2009","journal-title":"Vaccine"},{"issue":"January (115)","key":"10.1016\/j.vaccine.2012.12.054_bib0065","first-page":"115ra2","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.vaccine.2012.12.054_bib0070","doi-asserted-by":"crossref","first-page":"e3548","DOI":"10.1371\/journal.pone.0003548","article-title":"Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice","volume":"3","author":"Croyle","year":"2008","journal-title":"PLoS ONE"},{"issue":"January (5)","key":"10.1016\/j.vaccine.2012.12.054_bib0075","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.vaccine.2005.08.056","article-title":"N-fragment of edema factor as a candidate antigen for immunization against anthrax","volume":"24","author":"Zeng","year":"2006","journal-title":"Vaccine"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2012.12.054_bib0080","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.vaccine.2006.11.044","article-title":"Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut","volume":"25","author":"Lin","year":"2007","journal-title":"Vaccine"},{"issue":"December (1\u20132)","key":"10.1016\/j.vaccine.2012.12.054_bib0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virol.2006.07.037","article-title":"A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice","volume":"356","author":"Li","year":"2006","journal-title":"Virology"},{"issue":"October (20)","key":"10.1016\/j.vaccine.2012.12.054_bib0090","doi-asserted-by":"crossref","first-page":"10780","DOI":"10.1128\/JVI.77.20.10780-10789.2003","article-title":"Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier","volume":"77","author":"Xiang","year":"2003","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12018415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12018415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T17:27:44Z","timestamp":1595179664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12018415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0264410X12018415"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.12.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}